Litalir 500 mg – Kapseln (Paralleldistribution EMRA-MED Arzneimittel GmbH) Neu Rückruf | Humanarzneimittel | 07.07.2026 Rückruf aufgrund einer Abweichung des Aussehens
Austria BASG
Litalir 500 mg capsules (parallel distribution EMRA-MED Arzneimittel GmbH) – Recall
Original title: Litalir 500 mg – Kapseln (Paralleldistribution EMRA-MED Arzneimittel GmbH)Neu
Recall of Litalir 500 mg capsules due to deviation in appearance.
Applies from
2026-07-07
Published by Austria BASG. HealthSignal links to the original document; the summary above is extracted from the source text.